Schedule 13D ownership disclosure
IMMUNOMEDICS INC
Security class unavailable · CUSIP: 452907108
Event date: 2018-06-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-18-002623
- Form type
- SC 13D
- Filer
- IMMUNOMEDICS INC
- CIK
- CIK 722830
- Filed
- Jun 19, 2018
- Reporting period
- Jun 19, 2018
- Description
- Schedule 13D beneficial ownership